Search

everythinglearnresearchcommunity

for

Search:↓

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Alopecia areata affects 1 in 50 people, with non-White ethnic groups experiencing the most impact on mental health and work.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.

PCOS affects 11% of women, highlighting the need for standardized diagnosis.

African American adults and non-White children experience more hair loss episodes than White patients with alopecia areata.

People with Type 2 Diabetes are more likely to have a mite infestation called Demodex folliculorum.

Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Men with androgenetic alopecia may have a higher risk of heart rhythm problems.

Alopecia areata patients have higher risks of infections, lymphoma, heart issues, and death.

People with Alopecia Areata are more likely to have prediabetes and obesity.

COVID-19 vaccination may slightly increase the risk of hair loss, but benefits outweigh this risk.

Classical PCOS types A and B are most common and linked to higher health risks.

Certain fats in the blood are linked to an increased risk of male pattern baldness.

Melanoma characteristics vary by age, which could help doctors with diagnosis and prevention.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Skin problems like acne, excessive hair growth, and oily skin are common in women with PCOS and can help with early diagnosis.

Alopecia areata in elderly people is usually mild and responds well to treatment.

Actinic keratosis can lead to skin cancer, is more common in fair-skinned people, and can be reduced with sunscreen and treated effectively.

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Finasteride use is not clearly linked to an increased risk of male breast cancer.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

BMI is a simple, cost-effective tool for screening obesity and related diseases.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

Further research is needed to develop effective cancer prevention strategies.